Structures by: Giles I. D.
Total: 12
Pentakis(3,6-bis(pyrid-2-yl)-1,2,4,5-tetrazine-N,N',N'',N''') -decakis(acetonitrile-N)-pentairon(ii)bis hexafluoroantimonate(V) clathrate octakis(hexafluoroantimonate(V)) acetonitrile solvate
C80H70N40Fe5,10(SbF6)
Chemical Communications (Cambridge, United Kingdom) (2011) 47, 47 12604-12606
a=11.824(11)Å b=37.92(4)Å c=34.12(3)Å
α=90.00° β=90.00° γ=90.00°
Pentakis(3,6-bis(pyrimid-2-yl)-1,2,4,5-tetrazine- N,N',N'',N''')-decakis(acetonitrile-N)- pentairon(ii)hexafluoroantimonate(V) clathrate nonakis(hexafluoroantimonate(V)) acetonitrile toluene solvate'
C70H60N50Fe5,5(SbF6),6.5(CH3CN),C7H8
Chemical Communications (Cambridge, United Kingdom) (2011) 47, 47 12604-12606
a=16.180(3)Å b=21.569(4)Å c=23.123(4)Å
α=90.00° β=106.198(2)° γ=90.00°
Bis(hydrazinium) 5,5'-(3,3'-bi[1,2,4-oxadiazole]-5,5'-diyl)bis(1<i>H</i>-tetrazol-1-olate)
2(H5N2),C6N12O42
Acta Crystallographica Section E (2018) 74, 4 505-513
a=7.7660(7)Å b=13.6716(13)Å c=6.8655(7)Å
α=90° β=95.237(3)° γ=90°
Bis(hydroxyammonium) 5,5'-(3,3'-bi[1,2,4-oxadiazole]-5,5'-diyl)bis(1<i>H</i>-tetrazol-1-olate)
2(H4N1O1),C6N12O42
Acta Crystallographica Section E (2018) 74, 4 505-513
a=5.1011(9)Å b=18.494(3)Å c=7.0044(13)Å
α=90° β=92.624(2)° γ=90°
Bis(aminoguanidinium) 5,5'-(3,3'-bi[1,2,4-oxadiazole]-5,5'-diyl)bis(1<i>H</i>-tetrazol-1-olate)
2(C1H7N4),C6N12O42
Acta Crystallographica Section E (2018) 74, 4 505-513
a=7.9458(4)Å b=5.5586(2)Å c=20.6066(9)Å
α=90° β=97.647(2)° γ=90°
Bis(5-amino-1<i>H</i>-tetrazol-4-ium) 5,5'-(3,3'-bi[1,2,4-oxadiazole]-5,5'-diyl)bis(1<i>H</i>-tetrazol-1-olate)
2(C1H4N5),C6N12O42,4(H2O1)
Acta Crystallographica Section E (2018) 74, 4 505-513
a=24.783(2)Å b=12.7081(11)Å c=6.8396(6)Å
α=90° β=96.2890(10)° γ=90°
Di-μ-chlorido-bis[chloridobis(3,4,5-trimethyl-1<i>H</i>-pyrazole-\ κ<i>N</i>^2^)copper(II)]
C24H40Cl4Cu2N8
Acta Crystallographica Section E (2018) 74, 3 357-362
a=8.887(3)Å b=9.460(3)Å c=11.214(3)Å
α=85.408(4)° β=69.978(4)° γ=64.097(4)°
Aquatetrakis(3,4,5-trimethyl-1<i>H</i>-pyrazole-κ<i>N</i>^2^)copper(II) dinitrate
C24H42CuN8O,2(NO3)
Acta Crystallographica Section E (2018) 74, 3 357-362
a=20.107(7)Å b=7.8939(16)Å c=20.472(4)Å
α=90° β=102.651(2)° γ=90°
C38H72N13V
C38H72N13V
Inorganic chemistry (2006) 45, 22 8922-8929
a=27.0991(14)Å b=12.2152(6)Å c=18.0266(8)Å
α=90.00° β=130.270(2)° γ=90.00°
Fe(II) Square with bptz and [BF4]-
Fe4C64H56N328,8(BF41)
Journal of the American Chemical Society (2013) 135, 3039-3055
a=14.678(3)Å b=18.363(4)Å c=20.780(5)Å
α=85.364(3)° β=84.223(3)° γ=76.651(3)°
Pentakis(3,6-bis(pyrid-2-yl)-1,2,4,5-tetrazine-N,N',N'',N''') -decakis(acetonitrile-N)-pentairon(II)bis hexafluoroantimonate(V) clathrate octakis(hexafluoroantimonate(V)) acetonitrile solvate
C80H70N40Fe5,10(SbF6)
Journal of the American Chemical Society (2013) 135, 3039-3055
a=11.824(11)Å b=37.92(4)Å c=34.12(3)Å
α=90.00° β=90.00° γ=90.00°
Dimethylammonium 5,5'-(3,3'-bi[1,2,4-oxadiazole]-5,5'-diyl)bis(1<i>H</i>-tetrazol-1-olate)
2(C2H8N1),C6N12O42
Acta Crystallographica Section E (2018) 74, 4 505-513
a=6.0946(6)Å b=8.5197(8)Å c=9.2814(9)Å
α=68.259(3)° β=75.957(3)° γ=74.816(3)°